A. Nugent

发表

Recognition of emotional facial expressions in anxious and nonanxious depression.

Hannah Berg, E. Ballard, D. Luckenbaugh, 2016, Comprehensive psychiatry.

Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.

W. Drevets, D. Luckenbaugh, A. Nugent, 2006, Archives of general psychiatry.

Common genetic variants influence human subcortical brain structures

Thomas E. Nichols, Robert W. Williams, Benjamin S. Aribisala, 2015, Nature.

Identification of common variants associated with human hippocampal and intracranial volumes

Marisa O. Hollinshead, Lorna M. Lopez, Thomas W. Mühleisen, 2012, Nature Genetics.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review

Allison C. Nugent, Carlos A. Zarate, E. Ballard, 2015, Therapeutic advances in chronic disease.

Association between subcortical volumes and verbal memory in unmedicated depressed patients and healthy controls

M. Furey, W. Drevets, A. Nugent, 2012, Neuropsychologia.

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

E. Ballard, A. Nugent, C. Zarate, 2016, Current neuropharmacology.

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression

J. Roiser, D. Luckenbaugh, A. Nugent, 2014, Translational Psychiatry.

Grey matter differences in bipolar disorder: a meta‐analysis of voxel‐based morphometry studies

M. Phillips, D. Job, D. Dickstein, 2012, Bipolar disorders.

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects

Dennis S. Charney, Allison C. Nugent, Suzanne Wood, 2005, Biological Psychiatry.

Novel genetic loci underlying human intracranial volume identified through genome-wide association

Benjamin S Aribisala, Wiro J Niessen, Peter Kochunov, 2016, Nature Neuroscience.

Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum

Richard E Carson, Peter Herscovitch, W. Drevets, 2011, The European journal of neuroscience.

Multimodal imaging reveals a complex pattern of dysfunction in corticolimbic pathways in major depressive disorder

Jennifer W. Evans, A. Nugent, C. Zarate, 2019, Human brain mapping.

Evaluating global brain connectivity as an imaging marker for depression: influence of preprocessing strategies and placebo-controlled ketamine treatment

Jennifer W. Evans, A. Nugent, C. Zarate, 2020, Neuropsychopharmacology.

Replicating Global Brain Connectivity as an Imaging Marker for Depression – Influence of Preprocessing Strategies and Randomized Placebo-Controlled Ketamine Treatment

Jennifer W. Evans, A. Nugent, C. Zarate, 2019 .

Reduced thalamic volumes in major depressive disorder

W. Drevets, A. Nugent, C. Zarate, 2013, Psychiatry Research: Neuroimaging.

Reliability of 7T 1H‐MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between‐ and within‐sessions investigation

Li An, Jun Shen, Níall Lally, 2016, Journal of magnetic resonance imaging : JMRI.

Ketamine Has Distinct Electrophysiological and Behavioral Effects in Depressed and Healthy Subjects

E. Ballard, A. Nugent, T. Gould, 2017, Molecular Psychiatry.

Altered cerebral benzodiazepine receptor binding in post-traumatic stress disorder

W. Drevets, A. Nugent, D. Charney, 2018, Translational Psychiatry.

The Relationship between Glucose Metabolism, Resting-State fMRI BOLD Signal, and GABAA-Binding Potential: A Preliminary Study in Healthy Subjects and Those with Temporal Lobe Epilepsy

William H Theodore, A. Nugent, C. Zarate, 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.

Peter Herscovitch, Alexander Neumeister, W. Drevets, 2004, Archives of general psychiatry.

On-scalp magnetocorticography with optically pumped magnetometers: Simulated performance in resolving simultaneous sources

T. Holroyd, A. Nugent, S. Robinson, 2022, Neuroimage. Reports.

Automated subcortical segmentation using FIRST: Test–retest reliability, interscanner reliability, and comparison to manual segmentation

Wendy Bogers, W. Drevets, D. Luckenbaugh, 2013, Human brain mapping.

Mapping anticipatory anhedonia: an fMRI study

Jennifer W. Evans, C. Lejuez, E. Ballard, 2019, Brain Imaging and Behavior.

Magnetoencephalographic Correlates of Suicidal Ideation in Major Depression.

E. Ballard, A. Nugent, C. Zarate, 2019, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography.

W. Drevets, A. Nugent, G. Hasler, 2008, Archives of general psychiatry.

Pretreatment Differences in BOLD Response to Emotional Faces Correlate with Antidepressant Response to Scopolamine

M. Furey, W. Drevets, A. Nugent, 2015, The international journal of neuropsychopharmacology.

Serotonin versus catecholamine deficiency: behavioral and neural effects of experimental depletion in remitted depression

W. Drevets, A. Nugent, G. Hasler, 2015, Translational Psychiatry.

The Effect of Ketamine on Electrophysiological Connectivity in Major Depressive Disorder

E. Ballard, A. Nugent, C. Zarate, 2020, Frontiers in Psychiatry.

The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy

Peter Herscovitch, Dara M. Cannon, William H. Theodore, 2013, Neurology.

Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

E. Ballard, A. Nugent, C. Zarate, 2017 .

Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography

M. Furey, D. Luckenbaugh, A. Nugent, 2015, Acta Neuropsychiatrica.

Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder

M. Furey, A. Nugent, C. Zarate, 2018, The international journal of neuropsychopharmacology.

Relationship between serotonin-1A binding and HPA axis in subjects with major depression and healthy controls

D. Luckenbaugh, A. Nugent, W. Drevets, 2008, NeuroImage.

The Functional DRD3 Ser9Gly Polymorphism (rs6280) Is Pleiotropic, Affecting Reward as Well as Movement

A. Grace, W. Drevets, A. Nugent, 2013, PloS one.

Title : Lateralization and Gender Differences in the Dopaminergic Response to Unpredictable Reward in the Human Ventral Striatum Running title : Lateralized Dopamine Response to Reward

W. Drevets, A. Nugent, P. Herscovitch, 2011 .

Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder

S. Fromm, W. Drevets, A. Nugent, 2012, Scientific Reports.

Altered Cerebral -Aminobutyric Acid Type A–Benzodiazepine Receptor Binding in Panic Disorder Determined by [C]Flumazenil Positron Emission Tomography

W. Drevets, A. Nugent, G. Hasler, 2008 .

Alterations in neural correlates of autonomic control in females with major depressive disorder

W. Drevets, J. Thayer, A. Nugent, 2008 .

Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A preliminary PET study

W. Drevets, D. Luckenbaugh, A. Nugent, 2013 .

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Cassandra D. Leonardo, Charles P. Peterson, 2014, Brain Imaging and Behavior.

Novel genetic loci associated with hippocampal volume

Benjamin S Aribisala, Wiro J Niessen, Peter Kochunov, 2017, Nature Communications.

Cerebrospinal fluid monocyte chemoattractant protein-1 in alcoholics: support for a neuroinflammatory model of chronic alcoholism.

W. Drevets, A. Nugent, C. Zarate, 2014, Alcoholism, clinical and experimental research.

Functional anatomy of autobiographical memory recall deficits in depression

Kymberly D. Young, S. Fromm, M. Furey, 2011, Psychological Medicine.

The NIMH intramural healthy volunteer dataset: A comprehensive MEG, MRI, and behavioral resource

P. Bandettini, A. Nugent, S. Japee, 2022, Scientific data.

Magnetoencephalography biomarkers of suicide attempt history and antidepressant response to ketamine in treatment-resistant major depression.

E. Ballard, A. Nugent, C. Zarate, 2022, Journal of affective disorders.

Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression

W. Drevets, A. Nugent, D. Charney, 2013, European Neuropsychopharmacology.

Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

Jennifer W. Evans, M. Furey, A. Nugent, 2018, NeuroImage: Clinical.

Clinical Trial of the Potassium Channel Activator Diazoxide for Major Depressive Disorder Halted Due to Intolerability

E. Ballard, A. Nugent, C. Zarate, 2018, Journal of clinical psychopharmacology.

Habenula Volume in Bipolar Disorder and Major Depressive Disorder: A High-Resolution Magnetic Resonance Imaging Study

J. Roiser, W. Drevets, Sean Marrett, 2011, Biological Psychiatry.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Magnetoencephalography Studies in Mood Disorders

A. Nugent, 2021 .

Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study

Peter Herscovitch, Allison C. Nugent, Wayne C. Drevets, 2013, Biological Psychiatry.

Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder

Allison C. Nugent, Carlos A. Zarate, Alexander Neumeister, 2011, NeuroImage.

Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals

Jennifer W. Evans, J. Roiser, A. Nugent, 2020, Molecular Psychiatry.

Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Jennifer W. Evans, M. Furey, A. Nugent, 2019, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine

Allison C. Nugent, Minkyung Park, E. Ballard, 2017, Biological Psychiatry.

Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder

Allison C. Nugent, Maura L. Furey, Wayne C. Drevets, 2016, Psychiatry Research: Neuroimaging.

Cortical abnormalities in bipolar disorder investigated with MRI and voxel-based morphometry

Michael P. Milham, Linda M. Laird, Allison C. Nugent, 2006, NeuroImage.

Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression

A. Nugent, T. Gould, C. Zarate, 2020, Neuropsychopharmacology.

What we learn about bipolar disorder from large‐scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group

Erick Jorge Canales-Rodríguez, Dan J Stein, Melissa J. Green, 2020, Human brain mapping.

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder

W. Drevets, D. Luckenbaugh, A. Nugent, 2014, Bipolar disorders.

Habenula volume in post-traumatic stress disorder measured with high-resolution MRI

W. Drevets, A. Nugent, D. Charney, 2011, Biology of Mood & Anxiety Disorders.

The Effects of Tryptophan Depletion on Neural Responses to Emotional Words in Remitted Depression

S. Lalith Talagala, Gregor Hasler, Allison C. Nugent, 2009, Biological Psychiatry.

Neural correlates of change in major depressive disorder anhedonia following open-label ketamine

J. Roiser, D. Luckenbaugh, A. Nugent, 2015, Journal of psychopharmacology.

Functional Imaging of the Implicit Association of the Self With Life and Death.

Jennifer W. Evans, D. Dickstein, E. Ballard, 2019, Suicide & life-threatening behavior.

The Ethics of Clinical Trials Research in Severe Mood Disorders

A. Nugent, C. Zarate, F. Miller, 2017, Bioethics.

Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression.

W. Drevets, A. Nugent, C. Zarate, 2011, The international journal of neuropsychopharmacology.

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication

Dennis S. Charney, Allison C. Nugent, Carlos A. Zarate, 2010, NeuroImage.

Research on the pathophysiology, treatment, and prevention of suicide: practical and ethical issues

E. Ballard, A. Nugent, C. Zarate, 2019, BMC Psychiatry.

Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.

D. Luckenbaugh, A. Nugent, C. Zarate, 2016, The lancet. Psychiatry.

Can research in severe and treatment-resistant mood disorders be conducted safely? Outcome data from 12 years of clinical trials at the US National Institute of Mental Health

A. Nugent, Nicolas D. Iadarola, C. Zarate, 2016 .

DEVELOPING BIOMARKERS IN MOOD DISORDERS RESEARCH THROUGH THE USE OF RAPID‐ACTING ANTIDEPRESSANTS

M. Furey, A. Nugent, D. Ionescu, 2014, Depression and anxiety.

Biomarkers in mood disorders research: developing new and improved therapeutics.

M. Furey, A. Nugent, D. Ionescu, 2014, Revista de psiquiatria clinica.

Baseline mood-state measures as predictors of antidepressant response to scopolamine

M. Furey, W. Drevets, D. Luckenbaugh, 2012, Psychiatry Research.

Ketamine Alters Electrophysiological Responses to Emotional Faces in Major Depressive Disorder.

F. Carver, M. Furey, A. Nugent, 2020, Journal of affective disorders.

Altered interaction with environmental reinforcers in major depressive disorder: Relationship to anhedonia.

M. Furey, C. Lejuez, A. Nugent, 2017, Behaviour research and therapy.

Sex differences in the neural correlates of autonomic arousal: a pilot PET study.

Julian F Thayer, W. Drevets, J. Thayer, 2011, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Reduced Serotonin Type 1A Receptor Binding in Panic Disorder

Peter Herscovitch, Richard E. Carson, Dennis S. Charney, 2004, The Journal of Neuroscience.

Reduced posterior hippocampal volume in posttraumatic stress disorder.

Suzanne Wood, Alexander Neumeister, Meena Vythilingam, 2008, The Journal of clinical psychiatry.

7T 1H-MRS in major depressive disorder: a Ketamine Treatment Study

Jennifer W. Evans, J. Roiser, A. Nugent, 2018, Neuropsychopharmacology.

Selective reduction in amygdala volume in pediatric anxiety disorders: A voxel-based morphometry investigation

Monique Ernst, Ellen Leibenluft, Michael P. Milham, 2005, Biological Psychiatry.

Serotonin Transporter Binding in Bipolar Disorder Assessed using [11C]DASB and Positron Emission Tomography

Masanori Ichise, Dennis S. Charney, Allison C. Nugent, 2006, Biological Psychiatry.

DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.

A. Grace, W. Drevets, A. Nugent, 2013, The international journal of neuropsychopharmacology.

Serotonin Transporter Binding in Bipolar Disorder Assessed using ( 11 C)DASB and Positron

S. Fromm, W. Drevets, A. Nugent, 2006 .

Metacognition and emotion – How accurate perception of own biases relates to positive feelings and hedonic capacity

A. Nugent, C. Zarate, H. Brycz, 2020, Consciousness and Cognition.

Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression

W. Drevets, A. Nugent, C. Zarate, 2013, Journal of psychopharmacology.

Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration

Jennifer W. Evans, A. Nugent, C. Zarate, 2018, Biological Psychiatry.

Group differences in MEG-ICA derived resting state networks: Application to major depressive disorder

Richard Coppola, Stephen E. Robinson, Allison C. Nugent, 2015, NeuroImage.

Neural Correlates of Suicidal Ideation and Its Reduction in Depression

M. Furey, E. Ballard, D. Luckenbaugh, 2015, The international journal of neuropsychopharmacology.

Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study.

E. Leibenluft, M. Milham, W. Drevets, 2005, Archives of general psychiatry.

Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.

W. Drevets, J. Williams, A. Nugent, 2006, Archives of general psychiatry.

Bcl-2 Polymorphism Influences Gray Matter Volume in the Ventral Striatum in Healthy Humans

F. McMahon, W. Drevets, A. Nugent, 2009, Biological Psychiatry.

Basal ganglia activation localized in MEG using a reward task

F. Carver, T. Holroyd, A. Nugent, 2021 .

No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder.

W. Drevets, D. Luckenbaugh, A. Nugent, 2005, The American journal of psychiatry.

Deriving frequency‐dependent spatial patterns in MEG‐derived resting state sensorimotor network: A novel multiband ICA technique

Richard Coppola, Bruce Luber, Stephen E Robinson, 2017, Human brain mapping.

Shank3 as a potential biomarker of antidepressant response to ketamine and its neural correlates in bipolar depression.

D. Luckenbaugh, A. Nugent, C. Zarate, 2015, Journal of affective disorders.

Active suicidal ideation during clinical antidepressant trials

E. Ballard, D. Luckenbaugh, A. Nugent, 2017, Psychiatry Research.

Multilayer MEG functional connectivity as a potential marker for suicidal thoughts in major depressive disorder

E. Ballard, A. Nugent, C. Zarate, 2020, NeuroImage: Clinical.

Glutamatergic Signaling Drives Ketamine-Mediated Response in Depression: Evidence from Dynamic Causal Modeling

A. Nugent, C. Zarate, J. Gilbert, 2018, The international journal of neuropsychopharmacology.

The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder

F. McMahon, E. Ballard, D. Luckenbaugh, 2017, Journal of psychopharmacology.

Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [18F]fluorodeoxyglucose positron emission tomography study

W. Drevets, P. Bellgowan, A. Nugent, 2013, NeuroImage: Clinical.

Heart rate variability during motor and cognitive tasks in females with major depressive disorder

W. Drevets, J. Thayer, A. Nugent, 2011, Psychiatry Research: Neuroimaging.

Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder

Richard Coppola, Stephen E. Robinson, Allison C. Nugent, 2016, Psychiatry Research: Neuroimaging.

Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study

A. Nugent, C. Zarate, J. Gilbert, 2019, Psychiatry Research: Neuroimaging.

Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion

Peter Herscovitch, Dennis S. Charney, David Goldman, 2008, NeuroImage.

Title Effects of arterial cannulation stress on regional cerebral bloodflow in major depressive disorder

S. Fromm, W. Drevets, A. Nugent, 2019 .

Ketamine and Attentional Bias Toward Emotional Faces: Dynamic Causal Modeling of Magnetoencephalographic Connectivity in Treatment-Resistant Depression

A. Nugent, C. Zarate, J. Gilbert, 2021, Frontiers in Psychiatry.

Network Changes in Insula and Amygdala Connectivity Accompany Implicit Suicidal Associations

E. Ballard, A. Nugent, C. Zarate, 2020, Frontiers in Psychiatry.

A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression

E. Ballard, A. Nugent, C. Zarate, 2017, Journal of clinical psychopharmacology.

DRD 2 / ANKK 1 Taq 1 A polymorphism ( rs 1800497 ) has opposing effects on D 2 / 3 receptor binding in healthy controls and patients with major depressive disorder

A. Grace, W. Drevets, A. Nugent, 2013 .

Identification of common variants associated with human hippocampal and intracranial volumes

Marisa O. Hollinshead, Lorna M. Lopez, Thomas W. Mühleisen, 2012, Nature Genetics.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Cassandra D. Leonardo, Lorna M. Lopez, 2014 .

Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis

O. Abe, M. Phillips, D. Job, 2016, Molecular Psychiatry.

Novel genetic loci associated with hippocampal volume

Thomas E. Nichols, Benjamin S. Aribisala, Amelia A. Assareh, 2017, Nature Communications.

Ketamine and attentional bias to threat: dynamic causal modeling of magnetoencephalographic connectivity in treatment-resistant depression

A. Nugent, C. Zarate, J. Gilbert, 2021, medRxiv.

Using Neuroimaging to Decipher the Mechanism of Action of Ketamine: A Pathway to Novel Therapeutics?

A. Nugent, C. Zarate, 2017, Biological psychiatry. Cognitive neuroscience and neuroimaging.

Novel genetic loci underlying human intracranial volume identified through genome-wide association

Benjamin S. Aribisala, Nicola J. Armstrong, Amelia A. Assareh, 2016, Nature Neuroscience.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Benjamin S. Aribisala, Marisa O. Hollinshead, 2014, Brain Imaging and Behavior.

Amygdala volume in depressed patients with bipolar disorder assessed using high resolution 3T MRI: The impact of medication

J. Price, W. Drevets, Sean Marrett, 2010, NeuroImage.

The Effects of Tryptophan Depletion on Neural Responses to Emotional Words in Remitted Depression

S. Fromm, B. Sahakian, J. Roiser, 2009, Biological Psychiatry.

The Ethics of Clinical Trials Research in Severe Mood Disorders

A. Nugent, C. Zarate, F. Miller, 2017, Bioethics.

The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data

Thomas E. Nichols, Rita Z. Goldstein, Benjamin S. Aribisala, 2014, Brain Imaging and Behavior.

Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder

R. Coppola, A. Nugent, C. Zarate, 2016, Psychiatry Research: Neuroimaging.

Synaptic potentiation and rapid antidepressant response to ketamine in treatment-resistant major depression: A replication study

A. Nugent, C. Zarate, J. Gilbert, 2019, Psychiatry Research: Neuroimaging.

The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy

A. Nugent, P. Herscovitch, W. Theodore, 2013, Neurology.

Amygdala response to explicit sad face stimuli at baseline predicts antidepressant treatment response to scopolamine in major depressive disorder

M. Furey, W. Drevets, A. Nugent, 2016, Psychiatry Research: Neuroimaging.

Novel genetic loci underlying human intracranial volume identified through genome-wide association

Benjamin S. Aribisala, Nicola J. Armstrong, Amelia A. Assareh, 2016, Nature Neuroscience.

J. Roiser, D. Luckenbaugh, A. Nugent, 2016, Journal of magnetic resonance imaging : JMRI.

Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion

W. Drevets, A. Nugent, D. Charney, 2008, NeuroImage.

Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers

A. Nugent, Carlos A Zarate, Jennifer W Evans, 2024, Scientific reports.